As a new organization, we are supporting customers, patients, and communities in the moments that matter most. In the past two years every one of us has come to realize health’s profound impact on our ability to enjoy and experience life. It is the vitality that fuels hearts, minds, and spirits and is fundamental toQuidelOrtho
Employees: 1001-5000
Investors 1
| Date | Name | Website |
| 14.08.2022 | The Carlyl... | carlyle.co... |
Mentions in press and media 3
| Date | Title | Description |
| 05.03.2025 | Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director | ROCKVILLE, Md., March 5, 2025 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today announced the appointment of John Chiminski and Karen Flynn as non-executive members of its Board of... |
| 23.07.2024 | Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 | NEW YORK, July 23, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Avantor Inc. (NYSE:AVTR) will replace QuidelOrtho Corp. (NASD:QDEL) in the S&P MidCap ... |
| 25.07.2023 | QuidelOrtho Partners With BYG4lab to Strengthen Informatics Offerings | Strategic partnership will add middleware and data management solutions across the company’s diagnostics portfolio QuidelOrtho Corporation, a global provider of innovative in vitro diagnostics technologies designed for point-of-care setting... |